Action:
Amendment of opioid and buprenorphine prescribing regulations following updated federal guidance
Action 6263
General Information
| Action Summary |
Amends 18VAC85-21 based on updated guidelines issued by the Centers for Disease Control and Prevention and updated studies on effective use of opioids and buprenorphine. |
| Chapters Affected |
Only affects this chapter.
|
| Executive Branch Review |
This action will go through the normal Executive Branch Review process.
|
| RIS Project |
Yes [7609] |
| New Periodic Review |
This action will not be used to conduct a new periodic review.
|
Stages
Stages associated with this regulatory action.
| Stage ID |
Stage Type |
Status |
|
10045
|
Fast-Track
|
Stage complete. This regulation became effective on 01/02/2025. |
Contact Information
|
Name / Title:
|
Erin Barrett
/
Director of Legislative and Regulatory Affairs
|
|
Address:
|
Perimeter Center
9960 Mayland Drive, Suite 300
Henrico, VA 23233
|
|
Email Address:
|
erin.barrett@dhp.virginia.gov
|
|
Phone:
|
(804)750-3912
FAX: (804)915-0382
TDD: ()-
|
This person is the primary contact for this agency.
